BNP Paribas Financial Markets’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51 | Hold |
213
| – | – | ﹤0.01% | 4537 |
|
|
2025
Q1 | $42 | Hold |
213
| – | – | ﹤0.01% | 4460 |
|
|
2024
Q4 | $115 | Hold |
213
| – | – | ﹤0.01% | 4422 |
|
|
2024
Q3 | $202 | Hold |
213
| – | – | ﹤0.01% | 3312 |
|
|
2024
Q2 | $208 | Hold |
213
| – | – | ﹤0.01% | 3252 |
|
|
2024
Q1 | $337 | Sell |
213
-1,949
| -90% | -$3.08K | ﹤0.01% | 3246 |
|
|
2023
Q4 | $1.71K | Sell |
2,162
-1,891
| -47% | -$1.5K | ﹤0.01% | 3098 |
|
|
2023
Q3 | $3.16K | Buy |
4,053
+2,339
| +136% | +$1.82K | ﹤0.01% | 3011 |
|
|
2023
Q2 | $1.59K | Buy |
1,714
+595
| +53% | +$550 | ﹤0.01% | 3114 |
|
|
2023
Q1 | $1.22K | Buy |
1,119
+182
| +19% | +$198 | ﹤0.01% | 3036 |
|
|
2022
Q4 | $1.37K | Buy |
937
+515
| +122% | +$752 | ﹤0.01% | 3107 |
|
|
2022
Q3 | $454 | Sell |
422
-1,670
| -80% | -$1.8K | ﹤0.01% | 3817 |
|
|
2022
Q2 | $3.56K | Buy |
+2,092
| New | +$3.56K | ﹤0.01% | 3206 |
|
|
2019
Q2 | – | Sell |
-3,937
| Closed | -$16.9K | – | 3909 |
|
|
2019
Q1 | $16.9K | Hold |
3,937
| – | – | ﹤0.01% | 3349 |
|
|
2018
Q4 | $22.6K | Sell |
3,937
-6,365
| -62% | -$36.6K | ﹤0.01% | 2399 |
|
|
2018
Q3 | $140K | Hold |
10,302
| – | – | ﹤0.01% | 1927 |
|
|
2018
Q2 | $122K | Buy |
+10,302
| New | +$122K | ﹤0.01% | 2054 |
|